Church & Dwight Co., Inc. Q1 2026 Earnings Call Summary

Moby Intelligence

3 min read

Organic growth of 5% was primarily volume-driven, benefiting from a 2% tailwind as the company lapped prior-year retail inventory reductions.
Management attributed market share gains to a relentless focus on innovation, with new product launches expected to account for half of 2026 organic growth.
The company achieved the highest total distribution point gains in the CPG industry, driven by resets in TheraBreath, Hero, and laundry categories.
A balanced portfolio of value and premium offerings allowed the company to remain resilient as inflation and borrowing costs pressured consumer sentiment.
The ARM & HAMMER brand reached record laundry shares by capturing demand in the growing value segment, even while reducing promotional intensity.
International growth was led by the global expansion of Hero and TheraBreath, though performance was partially tempered by regional volatility in the Middle East.
Operational efficiency was highlighted by the seamless transition to an upgraded ERP system in April without customer disruption.

Full-year organic growth is projected at 3% to 4%, supported by a robust innovation pipeline and significant distribution gains hitting shelves in Q2.
Management identified $25 million to $30 million in incremental inflationary pressure from the Middle East conflict, primarily affecting oil-based derivatives and transportation.
The company plans to offset these new headwinds through accelerated productivity programs rather than consumer price increases, citing a lack of consumer appetite for higher pricing.
Q2 guidance assumes approximately 3% organic growth and 50 basis points of margin expansion, reflecting temporary transportation cost pressures ahead of mitigation efforts.
Strategic focus is shifting toward ARM & HAMMER expansion, international M&A, and oral care growth as organizational resources are freed up from the winding down of the VMS business agreement.

Reported sales are expected to decline 1.5% to 0.5% for the full year due to strategic portfolio exits executed in 2025.
The Middle East conflict remains a fluid risk factor, with management prepared to pivot to revenue growth management (RGM) or pricing if inflationary impacts exceed current estimates.
OxiClean experienced share declines due to distribution losses at a large club retailer, though management noted improving trends toward the end of Q1.
Toppik sales in Q1 were impacted by a strong Q4 holiday multipack sell-through, although consumption grew by low double digits and the brand is now being integrated with new innovation planned.